Brief: CA Healthcare Acquisition Corp Says LumiraDx To List On Nasdaq Via Merger With Co

LumiraDx

07/04/2021 06:13

April 7 (Reuters) - Ca Healthcare Acquisition Corp  CAHC.O :
    * LUMIRADX, A NEXT-GENERATION POINT OF CARE DIAGNOSTICS
TESTING
COMPANY TO LIST ON NASDAQ VIA MERGER WITH CA HEALTHCARE
ACQUISITION CORP
    * COMBINATION REFLECTS A VALUE OF $5.0 BILLION FOR LUMIRA'S
EXISTING EQUITY, BEFORE GIVING EFFECT TO TRANSACTION
    * LUMIRADX TO BE LED BY EXISTING CEO RON ZWANZIGER
    * NO EXISTING LUMIRADX SHAREHOLDERS ARE SELLING AS PART OF
TRANSACTION AND ALL PROCEEDS WILL BE USED TO FUND GROWTH
    * LUMIRADX SECURED $400 MILLION IN NEW DEBT FINANCING
    * LUMIRADX ESTIMATES 2021 REVENUE OF $600 MILLION - $1
BILLION

Source text for Eikon:  ID:nBwRdBwya 
Further company coverage:  CAHC.O 

 ((Reuters.Briefs@thomsonreuters.com;))